Gianforte’s federal disclosure shows he holds $2.5 million in stock in 12 pharmaceutical companies
Recently released personal financial records show New Jersey multi-millionaire Greg Gianforte is making millions in profits off of investments he has in 12 big pharmaceutical companies, including a number of multinational corporations.
“New Jersey multi-millionaire Greg Gianforte clearly has a conflict of interest that raises questions about why he wants to run for Montana’s U.S. House seat in the first place,” said Nancy Keenan, Executive Director of the Montana Democratic Party. “If Greg Gianforte is making money off of higher drug prices, we know that he won’t be fighting for Montanans’ interests when it comes to negotiating health care costs.”
Greg Gianforte owns $2.5 million in stock in 12 pharmaceutical companies including Bristol Myers Squibb, Pfizer, Merck & Company Inc., CSL, Abbvie, Novartis, Novo Nordisk, Shire PLC, Takeda, Taro Pharmaceutical industries, Allergan PLC and Bayer AG. The companies have come under fire for inflating drug prices increasing health care costs for hard-working Americans. In addition, many of Gianforte’s companies have lobbied against changing the way Medicare reimburses doctors for expensive drugs, which has resulted in increased costs for seniors.
U.S. House candidate, Rob Quist has spoken out against the high prescription drug costs saying pharmaceutical companies are putting profits before people.